Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
03.04.2025 04:53:40

Elon Musk’s Neuralink seeks patients globally to try its brain chips

Elon Musk’s computer-chip brain implant company Neuralink is seeking patients all around the world to trial its device that allows one’s thoughts to control a computer.Neuralink is looking for people with quadriplegia — those who are not able to use their arms or legs — to sign up for a clinical trial, it said in an April 2 post on X, the social media platform also owned by Musk.As of January, Neuralink has said three patients have been implanted with a device. All are quadriplegic and are testing a small brain implant that tracks neural activity to control a computer or smartphone as part of a clinical trial called the Precise Robotically Implanted Brain-Computer Interface, or PRIME study.Neuralink is one of several companies and academic institutions developing and testing so-called brain-computer interfaces, which vary from small wire-like implants as part of clinical trials to non-invasive devices akin to a hat.Source: NeuralinkNeuralink’s website says its clinical PRIME study, which will take around six years, is looking for quadriplegics with spinal cord injury or amyotrophic lateral sclerosis to use their thoughts to control a computer.Musk also heads vehicle maker Tesla and is the Trump administration's government cost-cutting czar. He has said he wants Neuralink to move beyond just allowing humans to operate computers by thinking and wants to help “give people superpowers.”First Neuralink patient reports no side effects after a yearNoland Arbaugh, Neuralink's first patient, said in a March 28 X post that he’s “had no negative side effects, neither physically nor psychologically” in the year after receiving his brain implant. Arbaugh, a quadriplegic, demoed his brain chip about a year ago by controlling a computer cursor to play chess and surf the web.Arbaugh said he’s now using his brain chip “for all sorts of things” and guessed he’s using it for over 10 hours a day.Related: SpaceX flight bankrolled by crypto investor launches first manned polar orbitHe said the company’s researchers were “figuring out how to control a wheelchair with the implant,” which he added he won’t use “unless it’s next to perfect. I think it benefits everyone if I don’t lose control and drive into traffic.”Arbaugh said he had found work as a traveling keynote speaker, which he attributed to Neuralink’s implant, which helped him write, research, and communicate online.“I can’t tell you how much hope and purpose this technology has provided me,” he wrote. “It’s only a matter of time before the implant is in dozens, then hundreds, then thousands of people.”Magazine: Crypto fans are obsessed with longevity and biohacking — Here’s why Weiter zum vollständigen Artikel bei Cointelegraph Weiter zum vollständigen Artikel bei Cointelegraph Weiter zum vollständigen Artikel bei Cointelegraph

Analysen zu BRAIN Biotech AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

3 Knaller-Aktien im BX Musterportfolio📈: Trane Technologies, Deutsche Boerse & Euronext mit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Trane Technologies
✅ Deutsche Boerse
✅ Euronext N.V

Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 Knaller-Aktien im BX Musterportfolio📈: Trane Technologies, Deutsche Boerse & Euronext mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 11’600.00 19.76
Short 11’935.88 14.00 BZISIU
Short 12’400.00 8.72
SMI-Kurs: 11’239.83 11.04.2025 17:31:21
Long 10’749.48 18.51 BCHSCU
Long 10’547.59 13.91 SSDMNU
Long 10’103.99 8.99 SSNM5U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}